Titan Pharmaceuticals Stock Gross Profit

TTNP Stock  USD 6.88  0.18  2.69%   
Titan Pharmaceuticals fundamentals help investors to digest information that contributes to Titan Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Titan Stock. The fundamental analysis module provides a way to measure Titan Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Titan Pharmaceuticals stock.
Last ReportedProjected for Next Year
Gross Profit72 K68.4 K
Gross Profit Margin 0.39  0.41 
As of 05/05/2024, Gross Profit Margin is likely to grow to 0.41, while Gross Profit is likely to drop slightly above 68.4 K.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Titan Pharmaceuticals Company Gross Profit Analysis

Titan Pharmaceuticals' Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Gross Profit

 = 

Revenue

-

Cost of Revenue

More About Gross Profit | All Equity Analysis

Current Titan Pharmaceuticals Gross Profit

    
  (4.37 M)  
Most of Titan Pharmaceuticals' fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Titan Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Titan Gross Profit Driver Correlations

Understanding the fundamental principles of building solid financial models for Titan Pharmaceuticals is extremely important. It helps to project a fair market value of Titan Stock properly, considering its historical fundamentals such as Gross Profit. Since Titan Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Titan Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Titan Pharmaceuticals' interrelated accounts and indicators.
-0.11-0.64-0.020.740.850.590.990.330.7-0.330.680.450.190.52-0.55-0.520.50.540.140.0
-0.11-0.61-0.28-0.25-0.18-0.87-0.09-0.22-0.15-0.190.15-0.88-0.890.250.320.29-0.04-0.30.18-0.07
-0.64-0.610.39-0.32-0.480.17-0.670.04-0.360.49-0.660.280.58-0.540.050.02-0.09-0.09-0.040.2
-0.02-0.280.390.120.020.2-0.150.810.10.92-0.110.170.160.17-0.58-0.540.340.56-0.060.02
0.74-0.25-0.320.120.930.570.730.470.8-0.240.440.60.320.45-0.73-0.670.370.7-0.120.04
0.85-0.18-0.480.020.930.570.850.410.76-0.310.550.560.250.55-0.61-0.530.430.630.0-0.07
0.59-0.870.170.20.570.570.570.330.48-0.030.220.940.820.05-0.53-0.480.280.51-0.080.06
0.99-0.09-0.67-0.150.730.850.570.240.7-0.450.650.440.190.51-0.49-0.450.470.480.15-0.03
0.33-0.220.040.810.470.410.330.240.630.570.070.290.140.34-0.9-0.750.440.92-0.21-0.14
0.7-0.15-0.360.10.80.760.480.70.63-0.260.30.430.230.38-0.86-0.730.380.86-0.23-0.08
-0.33-0.190.490.92-0.24-0.31-0.03-0.450.57-0.26-0.24-0.04-0.010.01-0.24-0.210.110.24-0.06-0.02
0.680.15-0.66-0.110.440.550.220.650.070.3-0.240.07-0.240.1-0.17-0.140.110.160.00.27
0.45-0.880.280.170.60.560.940.440.290.43-0.040.070.850.04-0.48-0.410.210.47-0.13-0.02
0.19-0.890.580.160.320.250.820.190.140.23-0.01-0.240.85-0.18-0.32-0.330.290.280.10.2
0.520.25-0.540.170.450.550.050.510.340.380.010.10.04-0.18-0.37-0.350.30.390.05-0.29
-0.550.320.05-0.58-0.73-0.61-0.53-0.49-0.9-0.86-0.24-0.17-0.48-0.32-0.370.89-0.46-0.980.230.01
-0.520.290.02-0.54-0.67-0.53-0.48-0.45-0.75-0.73-0.21-0.14-0.41-0.33-0.350.89-0.42-0.830.19-0.1
0.5-0.04-0.090.340.370.430.280.470.440.380.110.110.210.290.3-0.46-0.420.430.75-0.07
0.54-0.3-0.090.560.70.630.510.480.920.860.240.160.470.280.39-0.98-0.830.43-0.26-0.13
0.140.18-0.04-0.06-0.120.0-0.080.15-0.21-0.23-0.060.0-0.130.10.050.230.190.75-0.26-0.01
0.0-0.070.20.020.04-0.070.06-0.03-0.14-0.08-0.020.27-0.020.2-0.290.01-0.1-0.07-0.13-0.01
Click cells to compare fundamentals
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Competition

According to the company disclosure, Titan Pharmaceuticals reported (4.37 Million) of gross profit. This is 100.19% lower than that of the Pharmaceuticals sector and 100.46% lower than that of the Health Care industry. The gross profit for all United States stocks is 100.02% higher than that of the company.

Did you try this?

Run USA ETFs Now

   

USA ETFs

Find actively traded Exchange Traded Funds (ETF) in USA
All  Next Launch Module

Titan Fundamentals

About Titan Pharmaceuticals Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Titan Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Titan Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Titan Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

When determining whether Titan Pharmaceuticals is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Titan Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Titan Pharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Titan Pharmaceuticals Stock:
Check out Titan Pharmaceuticals Piotroski F Score and Titan Pharmaceuticals Altman Z Score analysis.
To learn how to invest in Titan Stock, please use our How to Invest in Titan Pharmaceuticals guide.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for Titan Stock analysis

When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Stocks Directory
Find actively traded stocks across global markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Commodity Directory
Find actively traded commodities issued by global exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Global Correlations
Find global opportunities by holding instruments from different markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Transaction History
View history of all your transactions and understand their impact on performance
Is Titan Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Titan Pharmaceuticals. If investors know Titan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Titan Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(7.41)
Revenue Per Share
0.245
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.75)
Return On Equity
(1.39)
The market value of Titan Pharmaceuticals is measured differently than its book value, which is the value of Titan that is recorded on the company's balance sheet. Investors also form their own opinion of Titan Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Titan Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Titan Pharmaceuticals' market value can be influenced by many factors that don't directly affect Titan Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Titan Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Titan Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Titan Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.